C5b is the larger, membrane-anchored fragment generated when C5 convertase cleaves C5, serving as the foundation stone for MAC (membrane attack complex) assembly. Unlike its sibling C5a which diffuses away as an inflammatory alarm signal, C5b remains tethered to the pathogen surface and initiates a sequential recruitment cascade of C6, C7, C8, and polymerized C9 to form a transmembrane killing channel. This represents the complement system's ultimate weapon—direct membrane perforation independent of phagocytic cells.
Think of C5b as the foundation anchor for building a tunnel through an enemy fortress wall. When the demolition crew (C5 convertase) splits the explosive charge (C5), one piece flies away as a flare (C5a) alerting reinforcements, while the other piece (C5b) embeds itself in the fortress wall like a magnetic anchor point. Within 2 minutes, this anchor must grab the first construction beam (C6), or the magnetic field decays and the whole operation fails. Once C6 locks on, the structure becomes stable—like switching from temporary scaffolding to permanent steel. Then C7 arrives with its lipid-seeking spike and punches through the outer wall layers, anchoring deep into the membrane like a piton hammered into rock. C8 follows, creating a pilot hole—a small breach that lets the first trickle of water through the dam. Finally, 10-18 copies of C9 polymerize around this pilot hole like interlocking barrel staves, forming a complete 10-nanometer cylinder that punches clean through both membrane layers. Water and ions flood through uncontrollably—the fortress drowns from within in seconds through osmotic lysis. The entire assembly from C5b anchor to complete tunnel takes under a minute when conditions are right.
The C5b-initiated MAC assembly follows a strict sequential cascade with time-dependent stability checkpoints:
C5 cleavage and C5b generation:
- C5 convertase (either C3bBb from alternative pathway or C4b2a from classical/lectin pathways) cleaves C5 into C5a (~11 kDa, anaphylatoxin) and C5b (~180 kDa, membrane anchor)
- C5b undergoes conformational change exposing hydrophobic binding sites for C6
- Critical timing: C5b has only 2-minute half-life in active conformation before irreversible inactivation
- C5b remains surface-bound via non-covalent interactions with C3b molecules
C5b-6 complex formation:
- C6 (~110 kDa) binds to nascent C5b within seconds, forming stable C5b-6 complex
- This interaction prevents C5b inactivation and extends complex half-life to ~60 minutes
- C5b-6 complex can dissociate from membrane and bind to nearby surfaces (bystander lysis risk)
C5b-7 membrane insertion:
- C7 (~100 kDa) binds to C5b-6, exposing hydrophobic domains on C7
- C7's hydrophobic tail inserts into lipid bilayer like a molecular piton, anchoring the entire complex
- C5b-7 becomes irreversibly membrane-embedded
- C5b-7 creates initial membrane perturbation but not yet a functional pore
C5b-8 pore initiation:
- C8 (~150 kDa, heterotrimeric protein with α, β, γ chains) binds to C5b-7
- C8α chain penetrates membrane bilayer, creating initial small pore (~1 nm diameter)
- This creates sublytic MAC—sufficient to trigger cell signaling but not immediate lysis
- Ion leakage begins through C8α channel
C9 polymerization and MAC completion:
- C5b-8 recruits first C9 molecule (~70 kDa), which undergoes dramatic conformational change
- C9 inserts amphipathic α-helices into membrane and exposes binding sites for additional C9 molecules
- 10-18 C9 molecules polymerize in ring formation around C5b-8 core (average 12-16)
- Poly-C9 forms transmembrane β-barrel structure with internal diameter of 10 nm
- Complete MAC visible as ring structures on electron microscopy
Lytic mechanism:
- 10-nm pore disrupts membrane potential and osmotic gradient
- Unregulated influx of H₂O, Na⁺, Ca²⁺ into cell
- Efflux of K⁺, organic molecules out of cell
- Cell swelling and osmotic lysis within seconds to minutes
- Single MAC pore can cause bacterial lysis; nucleated cells may require multiple MACs
graph TD
A[C5 convertase cleaves C5] --> B[C5b generated]
B --> C{C5b active <2 min}
C -->|Yes| D["C6 binds → C5b-6"]
C -->|No| E[C5b inactivated]
D --> F["C7 binds → C5b-7<br/>membrane insertion"]
F --> G["C8 binds → C5b-8<br/>small pore 1nm"]
G --> H[First C9 binds]
H --> I["C9 polymerization<br/>10-18 copies"]
I --> J["Complete MAC<br/>10nm pore"]
J --> K[Ion/water influx]
K --> L["Osmotic lysis<br/>seconds to minutes"]
G -.sublytic doses.-> M["Cell signaling<br/>inflammation"]
style B fill:#ffcccc
style D fill:#ffe6cc
style F fill:#fff4cc
style G fill:#e6f3ff
style J fill:#ff9999
style L fill:#ff6666
Regulatory control mechanisms:
- Host cells protected by CD59 (protectin) which binds C8/C9 and prevents MAC assembly
- Vitronectin (S-protein) binds soluble C5b-7 complexes preventing membrane insertion
- Clusterin binds C7/C8/C9 preventing membrane insertion
- Regulatory protein absence or malfunction causes paroxysmal nocturnal hemoglobinuria
C5b-initiated MAC formation represents the complement system's direct killing capacity, independent of cellular phagocytosis—critical when innate immunity must act before adaptive responses mobilize. In cPNI practice, this connects to Metamodel 0 (evolutionary mismatch) and Metamodel 3 (chronic inflammation): the MAC system evolved for acute bacterial threats but becomes pathological when chronically activated against self-tissues.
Terminal complement deficiency presentations:
- Patients with C5-C9 component deficiencies experience recurrent Neisseria meningitidis and gonorrhoeae infections (8,000-fold increased risk)
- Gram-negative bacteria particularly susceptible due to thin peptidoglycan layer beneath outer membrane allowing MAC access
- Gram-positive bacteria more resistant—thick peptidoglycan wall prevents MAC membrane insertion
- Deficiency testing: CH50 (total complement hemolytic activity) will be zero with terminal pathway defects
Pathological MAC activation:
Sublytic MAC effects:
- C5b-8 or incomplete C5b-9 assemblies (insufficient C9) create sublytic MAC
- Rather than lysing cell, sublytic MAC triggers intracellular signaling cascades
- Activates NF-κB → IL-6, IL-8, TNF-α production
- Stimulates prostaglandin synthesis via COX-2 induction
- Triggers calcium influx activating protein kinases
- Upregulates adhesion molecules (VCAM-1) on endothelium
- This explains how complement contributes to chronic inflammation even without cell lysis
Clinical intervention implications:
- C5 inhibitors (eculizumab, ravulizumab) block C5 cleavage preventing both C5a and C5b generation
- Used clinically in paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, myasthenia gravis
- Anti-C5 therapy increases Neisseria infection risk—patients require meningococcal vaccination
- Measuring C5b-9 (soluble MAC) in serum/plasma provides biomarker of complement activation
- Normal serum C5b-9: <300 ng/mL; elevated in active autoimmune disease, sepsis, transplant rejection
Connection to selfish immune system concept:
- MAC formation consumes metabolic resources (C5-C9 protein synthesis requires hepatic amino acids, energy)
- Body prioritizes pathogen killing over metabolic efficiency when infection threatens survival
- Chronic MAC activation (e.g., autoimmunity) drains metabolic reserves contributing to fatigue, cachexia
- The 2-minute C5b activation window represents evolutionary optimization—rapid assembly when needed, automatic shutdown preventing waste
- C5b half-life: 2 minutes in active conformation; must bind C6 within this window or becomes permanently inactive
- MAC pore diameter: 10 nanometers (100 Ångströms) visible as ring structures on electron microscopy
- C9 polymerization: 10-18 copies (typically 12-16) required for complete transmembrane channel
- Lysis kinetics: single MAC pore can cause bacterial lysis within seconds; nucleated mammalian cells typically require multiple MAC assemblies due to membrane repair capacity
- Gram-negative susceptibility: 100-1000× more susceptible to MAC than gram-positive bacteria due to outer membrane structure allowing direct membrane access
- Sublytic threshold: C5b-8 or incomplete C5b-9 assemblies trigger inflammatory signaling without causing cell death
- Clinical biomarker: serum C5b-9 (soluble MAC) normal range <300 ng/mL; elevated in active complement-mediated diseases
- C5-C9 deficiency incidence: approximately 1 in 10,000 individuals; increases Neisseria infection risk 8,000-fold
- Bystander lysis: C5b-6 complex can dissociate from initial surface and insert into nearby host cell membranes causing collateral damage
- Regulatory protein escape: CD59 deficiency (paroxysmal nocturnal hemoglobinuria) allows MAC formation on host red blood cells causing hemolytic anemia
- Ischemia-reperfusion timeline: MAC deposition peaks 4-24 hours post-reperfusion, contributing to delayed tissue injury
- Evolutionary conservation: MAC components highly conserved across vertebrates; fish, amphibians, mammals all use C5b-C9 cascade
- C5a — generated simultaneously from C5 cleavage; C5a diffuses as inflammatory chemoattractant while C5b remains membrane-bound to nucleate MAC
- MAC — C5b serves as the obligate foundation molecule that initiates and scaffolds the complete membrane attack complex
- C5 convertase — the enzyme complex (C3bBb or C4b2a) that cleaves C5 generating both C5a and C5b fragments
- C3b — precursor opsonin that forms C5 convertase; C3b-mediated opsonization precedes C5b-MAC formation in complement cascade
- C6 — first protein recruited by C5b (within 2-minute window) forming stable C5b-6 complex that resists inactivation
- C7 — binds C5b-6 and inserts hydrophobic domains into lipid bilayer, irreversibly anchoring MAC assembly to membrane
- C8 — recruited by C5b-7 complex; C8α chain penetrates membrane creating initial 1-nm pilot pore (sublytic MAC)
- C9 — polymerizes (10-18 copies) on C5b-8 scaffold forming complete 10-nm transmembrane β-barrel channel
- osmotic lysis — MAC-mediated cell death mechanism caused by unregulated ion/water influx through 10-nm pore disrupting osmotic balance
- complement system — C5b represents terminal pathway activation providing direct pathogen killing alternative to opsonization-phagocytosis
- Opsonization — C3b-mediated tagging for phagocytosis; complement provides dual killing mechanisms (opsonization vs MAC)
- bacteria — primary evolutionary targets of C5b-MAC formation; particularly gram-negative bacteria susceptible to membrane perforation
- gram-negative bacteria — thin peptidoglycan layer makes outer membrane vulnerable to MAC insertion causing rapid lysis
- Neisseria — patients with C5-C9 deficiencies experience recurrent Neisseria meningitidis/gonorrhoeae infections (8,000× risk increase)
- innate immunity — MAC provides rapid pathogen killing without requiring antibodies, T cells, or prior antigen exposure
- inflammation — sublytic MAC doses (C5b-8 or incomplete C5b-9) trigger NF-κB activation and inflammatory cytokine production
- ischemia-reperfusion injury — reperfusion triggers massive C5b-MAC deposition on endothelium causing additional tissue damage beyond initial ischemia
- autoimmune disease — inappropriate C5b-MAC assembly on self-tissues drives damage in systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis
- cytokine storm — sublytic MAC upregulates IL-6, IL-8, TNF-α production contributing to systemic inflammation
- endothelial dysfunction — MAC deposition on vascular endothelium increases permeability and upregulates adhesion molecules (VCAM-1)
- calcium — MAC pores allow unregulated Ca²⁺ influx triggering intracellular signaling cascades and protein kinase activation
- ATP — cell attempts to pump ions out through Na⁺-K⁺ ATPase depleting ATP reserves before succumbing to lysis
- CD59 — host cell surface protein that binds C8/C9 preventing MAC assembly; deficiency causes paroxysmal nocturnal hemoglobinuria
- acute phase response — hepatic synthesis of complement proteins including C5-C9 increases during acute phase response to infection
- chronic inflammation — persistent MAC activation drains metabolic resources (amino acids, energy) contributing to fatigue and cachexia
- NF-κB — sublytic MAC activates NF-κB transcription factor driving inflammatory gene expression even without cell lysis
- COX-2 — sublytic MAC upregulates COX-2 expression increasing prostaglandin synthesis and inflammatory signaling
- neutrophils — complement-mediated bacteria killing complements neutrophil phagocytosis; MAC provides immediate killing while neutrophils mobilize
- Module 4 — complement cascade and terminal pathway
- Module 5 — immune system integration and MAC formation in wound healing context